Position in ADCT
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$14,900
-$23,046 QoQ
Shares Held
13,926
+37.6% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#78
of 113 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026R Squared Ltd holds $1,419,676 across 8 Drug Manufacturers - Specialty & Generic names. ADCT ranks #8 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
50,307 | $469,364 | |
| 2 | ANIK |
Anika Therapeutics, Inc.
|
27,065 | $395,960 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
20,263 | $202,630 | |
| 4 | LFCR |
Lifecore Biomedical, Inc. De
|
24,580 | $129,045 | |
| 5 | TLRY |
Tilray Brands, Inc.
|
27,861 | $125,095 | |
| 6 | SIGA |
Siga Technologies Inc
|
14,793 | $53,846 | |
| 7 | AKBA |
Akebia Therapeutics, Inc.
|
25,295 | $28,836 | |
| 8 | ADCT |
ADC Therapeutics SA
This page
|
13,926 | $14,900 |
All Filings in ADCT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,900 | 13,926 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $37,946 | 10,119 | Shares | Sole | 2026-04-29 | |
| 2025-09-30 | $58,856 | 14,714 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||